ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

Cancer Meetings Listed

October 24, 1997

NCI Seen Shifting Away From Comprehensive Center Emphasis Toward Encouraging Clinical Excellence

April 30, 1976

“Mini-Transplantation” In Testing For Treatment Of Multiple Myeloma

January 25, 2002

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

In Brief: Coalition Begins Campaign To Educate Public

February 3, 1995